Frontlight ResearchEarly access
Trial site
Stanford School of Medicine /Division of Neuromuscular Medicine
- 2running trials
The trials here
What the 2 trials at this site are about, from their registry records.
- Conditions
- Duchenne muscular dystrophy2 trials
- Phase
- Phase 2/31 trial
- Status
- Active, not recruiting1 trial
- Enrolling by invitation1 trial
- Lead sponsor
- REGENXBIO Inc.2 trials
Running trials
Enrolling by invitation
Active, not recruiting
AFFINITY DUCHENNE: RGX-202 Gene Therapy in Participants With Duchenne Muscular Dystrophy (DMD)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Duchenne muscular dystrophy1 recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026